Regadenoson .08 mg/mL

Regadenoson .08 mg/mL is a pharmaceutical injection used for specific medical imaging procedures. This solution is designed to enhance diagnostic accuracy in certain cardiovascular assessments.

Regadenoson .08 mg/mL is primarily used as a pharmacological stress agent in myocardial perfusion imaging. This helps in evaluating blood flow to the heart muscle, aiding in the diagnosis of coronary artery disease. Regadenoson is often administered intravenously to simulate the effects of exercise on the heart, making it useful for patients who cannot undergo physical stress tests.

Regadenoson .08 mg/mL works by dilating the blood vessels in the heart, which can temporarily increase blood flow. This action helps to identify areas of the heart that may not be receiving adequate blood supply. Common effects may include shortness of breath, flushing, and headache, which typically subside quickly.

Regadenoson .08 mg/mL should be used with caution in patients with asthma, low blood pressure, or a history of seizures. It is important to follow the advice of a healthcare professional regarding its use. Always store the solution as directed and ensure it is used before the expiration date.

Regadenoson .08 mg/mL may interact with certain medications, including those that affect blood pressure or heart rate. It is advisable to inform your healthcare provider about all medications you are taking before using this solution. Avoid consuming alcohol or other substances that may affect cardiovascular function.